- Featured Product
- KD/KO Validated
RFX5 Polyclonal antibody
RFX5 Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
WB, ELISA
Conjugate
Unconjugated
Cat no : 12137-1-AP
Synonyms
Validation Data Gallery
Applications:
Tested Applications
| Positive WB detected in | HeLa cells, Jurkat cells, K-562 cells, Raji cells |
Planning an IHC experiment? We recommend our IHCeasy RFX5 Ready-To-Use IHC Kit. RFX5 primary antibody included.
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Sample-dependent, check data in validation data gallery | |
Published Applications
| KD/KO | See 1 publications below |
| WB | See 2 publications below |
Product Information
12137-1-AP targets RFX5 in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | RFX5 fusion protein Ag2783 相同性解析による交差性が予測される生物種 |
| Full Name | regulatory factor X, 5 (influences HLA class II expression) |
| Calculated molecular weight | 616 aa, 65 kDa |
| Observed molecular weight | 65 kDa |
| GenBank accession number | BC017471 |
| Gene symbol | RFX5 |
| Gene ID (NCBI) | 5993 |
| RRID | AB_2179039 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for RFX5 antibody 12137-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Sci Rep RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
| ||
Chin Med J (Engl) Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis. |
